Calidi Biotherapeutics Competitors and Similar CompaniesClear all

Calidi Biotherapeutics's competitors and similar companies include Immutep, Day One Biopharmaceuticals, Bexion Pharmaceuticals and Iksuda Therapeutics.

	Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.	Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.	Day One Biopharmaceuticals Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer.	Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
Founding Date	Founding Date 2014	Founding Date 2001	Founding Date 2018	Founding Date 2006	Founding Date 2007
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations San Diego, US HQ Bernried, DE	Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE	Locations South San Francisco, US HQ	Locations Covington, US HQ	Locations Newcastle upon Tyne, GB HQ Newton, US
Employees	Employees 327% increase	Employees 2427% decrease	Employees 20	Employees 274% increase	Employees 43
Valuation ($)	Valuation ($) N/A	Valuation ($) 282.4 m	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $158.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income ($61.4m) (FY, 2025)	Net income ($107.3m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 8.2m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 16.6m (about 7 years ago)	Latest funding round $ 47m (almost 5 years ago)
Total funding raised	Total funding raised $ 20m	Total funding raised N/A	Total funding raised $ 60m	Total funding raised $ 16.6m	Total funding raised $ 47m